Baekrokdam Medical Evaluation and Medication Guide · Read First
Herbal medicine, oral medications, and GLP-1 injections are neither the same products nor direct substitutes, and superiority cannot be determined solely by average weight loss rates from different studies. You must choose with the prescribing medical staff by comparing administration methods, diseases, current medications, discomforts to avoid, tracking possibilities, and discontinuation or transition plans using the same set of criteria.
To answer your question directly
Do not determine superiority based solely on average weight loss rates from different studies. You should choose during your medical evaluation by comparing your ability to use injections, side effects you wish to avoid, existing conditions and medications, plans after stopping treatment, and the possibility of follow-up tracking using the same criteria.
Apply for Gambijeong consultation →This page answers the following
If you do not have the above symptoms and your condition is stable, please check the recording items on this page first and then request a follow-up visit to Baekrokdam.
Inquiries during medication
Dosage, discomfort, and weight loss speed can be re-evaluated during a follow-up visitIf you record and send your questions and bodily changes, the director will review your current intake progress. If a direct examination is necessary, a clinic visit may be requested.
Report Baekrok Gambi-jeong usage →Read this first
Do not conclude that a treatment is better for an individual by directly contrasting the average weight loss figures of different treatments.
Compare the administration method, conditions/medications, past reactions, discomforts to avoid, and trackability using the same criteria.
Do not arbitrarily stop, cross-use, or overlap remaining Gambijeong (weight loss herbal medicine) with other medications or injections; instead, seek medical evaluation for a proper transition.
If you do not know the name, ingredients, and dosage of your medication, you may apply incorrect information even if it is categorized as 'weight loss medicine.' This page does not replace individual prescription changes or emergency medical care.
Between diet herbal medicine, oral obesity treatments, and GLP-1 Injections are not the same medication just in a different formulation. The actual composition, mechanism of action, indications, contraindications, administration/dosage methods, and monitoring items are different. They cannot be substituted for one another based solely on the common expression that they "reduce appetite."
Subjects, starting weight, duration, and lifestyle support vary by study. You should not conclude that one treatment is better for you simply by comparing the average of one study with the average of another. Individual results depend on whether the treatment is right for you, whether you can maintain it consistently, and your actual response.
Consider whether daily oral intake, injections at fixed intervals, storage, and schedule management fit your lifestyle. While preferences, such as disliking injections or preferring pills, are important, convenience alone cannot be a reason to skip safety checks regarding your medical conditions or current medications.
Weight loss medicine, Injection, GambihwanDo not write only the method; record the medication name, dosage, date of last use, and the prescribing institution. Labels and usage instructions can differ by product even within the same class. Please prepare photos of the packaging and your prescriptions.
Disclose all thyroid, cardiovascular, diabetes, digestive diseases, mental health treatments, and current medications. Just because one treatment was unsuitable does not automatically mean another is safe. The possibility of pregnancy or breastfeeding must also be confirmed before starting.
Oral medications and Korean herbal medicine may cause throbbing, insomnia, or digestive discomfort; GLP-1 treatments have specific check-items such as nausea, vomiting, and abdominal pain depending on the product. Enduring discomfort does not mean the effect is better; record the relationship between the product, dosage, and timing.
Rapid weight loss or decreased intake can affect muscle and nutritional status regardless of the type of treatment. Check not only the weight number but also food intake, protein consumption, possible strength activities, and changes in body composition.
Oral obesity treatments and appetite suppressants are not the same. Actual ingredients, indications, duration of use, contraindications, and precautions may differ. If you do not know the name of a medication you took in the past, find the prescription or medication envelope and bring it to your appointment; do not assume it is in the same class based on memory alone.
Wegovy, Saxenda, and Mounjaro are not the same injections; their dosage stages, indications, and precautions differ. Do not apply another person's dosage increase schedule or method for handling missed injections. Confirm based on the prescribing physician of your current product and the official medication guide.
Check what medical history and test results are needed before starting, and how the following will be monitored during use in addition to weight: pulse·blood pressure·sleep, digestion, and intake. Do not judge the superiority of a treatment by whether there are more or fewer tests; instead, ask if they are necessary to identify your specific risks.
Consider initial costs, changes according to dosage stages, whether consultations, tests, and follow-ups are included, and the plan after discontinuation. Choosing based only on the cheapest month or a large discount may lead to unexpected inconveniences or overlook the actual burden when switching treatments.
Instead of stopping at "Western medicine didn't work" or "I had a yo-yo effect with injections," record the product, dosage, duration, changes achieved, reason for discontinuation, and subsequent appetite and weight. Detailed records are necessary to avoid repeating the same problems and to realistically set expectations and limits for a new treatment.
Baekrok Gambi-jeong is not prescribed immediately simply because injections or oral medications were not suitable. Baekrok Gambi-jeong is a tablet-form Korean herbal medicine with the same composition, and it is determined whether this prescription is appropriate through an in-person or remote medical evaluation. If it is not suitable, it will not be prescribed, or other treatments may be recommended.
The best option for you is not determined solely by trends, reviews, or high average weight loss figures. You must verify your eligibility for injections, discomforts you wish to avoid, the possibility of testing and follow-up, costs, and the plan after discontinuation with the prescribing medical staff.
Do not arbitrarily alternate remaining Gambi-jeong with other oral medications or injections on different dates. The effects and adverse reactionsresidues may remain, making it difficult to distinguish the cause. Before switching, inform the medical staff of both providers about all products used and the date of last use.
Organize the current product, dosage, date of last use, effects achieved, reason for discontinuation, and remaining symptoms. Accurately evaluating your previous state is more important than starting a new treatment quickly. The necessity of a washout period or testing will be determined during the medical evaluation.
Do not look only at weight loss during treatment; check how appetite, diet, sleep, activity, and weight trends will be managed after discontinuation, and whether there are criteria for seeking medical evaluation again. No treatment can guarantee that it will automatically prevent the yo-yo effect.
Chest pain, fainting, severe shortness of breath, changes in consciousness, seizures, severe and persistent abdominal pain, repeated vomiting that makes it difficult to maintain hydration, and dehydrationif these occur, do not search for the next treatment option and seek medical evaluation immediately. Also, inform your current prescribing institution of the product used and the last dosage.
Ask, “Based on my medical history and current medications, which options should I avoid? What discomforts would require me to stop this treatment? When will the efficacy and safety be re-evaluated? What is the plan after discontinuation?” These four questions are more useful for personal decision-making than a simple ranking of efficacy.
Choosing between diet Korean herbal medicine, oral medications, or GLP-1 injections is not about picking a winner. It is a process of placing the medications actually taken, health status, administration feasibility, expected discomfort, and follow-up/switching plans on the same table to determine a sustainable path for both the medical staff and yourself.
Even after a decision is made, there is no need to stick stubbornly to the first choice. At the agreed evaluation point, review the benefits and burdens again to maintain, adjust, discontinue, or switch to another medical evaluation, but do not overlap treatments on your own.
Verification of Evidence
During medical evaluation
Individual prescriptions cannot be determined by public guides alone. During a medical evaluation, the name and dosage of medications being taken, medical history, and current symptoms are verified together.
Medical professional who reviewed this text
We have reviewed the comparison of selection, safety, tracking, discontinuation, and transition between diet Korean herbal medicine, oral obesity treatments, and GLP-1 injections. During a medical evaluation, the next steps are determined together by confirming the individual's actual prescription, administration time, and current symptoms.
Medical information may be updated. Please prioritize the prescription, medication guide, and instructions provided by your attending medical staff.
Questions
It is not possible to determine individual superiority by directly contrasting average weight loss rates from different studies. Please compare medical history, current medications, administration methods, discomforts, and post-discontinuation plans during a medical evaluation.
They are not the same medication or standard ingredients. The actual prescription composition, mechanism of action, contraindications, concomitant medications, dosage, and how to inquire after administration must each be verified.
Do not switch on your own. After confirming the current medication, dosage, last administration date, and remaining symptoms, it must be determined if a new treatment is appropriate and when to start it.
The level of risk cannot be determined by the name of the treatment alone. Tracking of individual medical history, dosage, concomitant medications, supplements, and actual adverse reactions is necessary.
No treatment can be guaranteed to automatically prevent weight regain after discontinuation. Please compare maintenance support, appetite and lifestyle tracking, and re-consultation plans together.
Source
This was used as a framework to compare treatment selection, lifestyle support, and long-term tracking together.
This reflects the need to verify indications, dosage, contraindications, and adverse reactions for each GLP-1 product.
This ensures that injection products are not lumped into a single category and that the label of the medication actually taken is verified.
This reflects the limitations of applying evidence to Korean herbal medicine treatments, as well as principles for safety and follow-up visits during administration.
This was used for the principle of sharing all products and the last date of use when transitioning or combining treatments.
Reviewing Medical Staff
Choi Yeon-seung, Doctor of Korean MedicineChief Director · Editor of Korean Medicine Atlas · BRC Researcher
Page Summary
Herbal medicine, oral medications, and GLP-1 injections are not the same products nor substitutes for one another, and their superiority cannot be determined solely by average weight loss rates from different studies. You must choose with your prescribing medical provider by evaluating the administration method, existing conditions/medications, discomforts to avoid, traceability, and plans for discontinuation or switching using the same set of criteria.
Key Points